Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Going on holiday with weight-loss jabs could land you in a lot of trouble as they are banned or regulated in some countries ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...